Pharmacological Inhibitors in Cell Signaling

JQ1 (2 (link)) and CGP57380 (21 (link)) were purchased from Tocris Bioscience; OTX-015 (22 (link)) and ARV-825 (11 (link)) were obtained from Selleckchem; U0126 (23 (link)) was from Cell Signaling; and SB202190 (24 (link)) and NSC23766 (25 (link)) were purchased from Calbiochem.

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Pham T.N., Kumar K., DeCant B.T., Shang M., Munshi S.Z., Matsangou M., Ebine K, & Munshi H.G. (2018). Induction of MNK kinases-dependent eIF4E phosphorylation by inhibitors targeting BET proteins limits efficacy of BET inhibitors. Molecular cancer therapeutics, 18(2), 235-244.

Publication 2018

CGP57380 OTX-015 ARV-825 U0126

Arv 825 Cgp57380 Nsc23766 Sb202190 U0126

Corresponding Organization : Jesse Brown VA Medical Center

Top 5 similar protocols

Variable analysis

independent variables

CGP57380
OTX-015
ARV-825
U0126
SB202190
NSC23766

dependent variables

Not explicitly mentioned

control variables

Not explicitly mentioned

positive controls

Not specified

negative controls

Not specified

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!